medline.ch Onkologie Gynäkologische Tumoren

	Comprehensive insight into nimbolide response against breast cancer treatment: present evidence, emerging strategy and future direction. Mol Biol Rep Sarangi A, Kashyap A, Panda SS, Sahoo S, Sahoo SK. PMID: 42189294 [PubMed - in process]
	Adverse childhood experiences, adult adiposity, and risk of young-onset breast cancer subtypes in a population-based case-control study. Cancer Causes Control Marcus Post L, Cho YI, Topitzes J, Do D, Pathak DR, Hamilton AS, Nuru-Jeter AM, Hirko KA, Kwarteng JL, Houang R, Schwartz AG, Velie EM. PMID: 42189276 [PubMed - in process]
	Primary care continuity and breast cancer survival: a retrospective cohort study. Cancer Causes Control Walsh R, Lofters A, Groome P, Moineddin R, Krzyzanowska MK, Griffiths R, Grunfeld E. PMID: 42189262 [PubMed - in process]
	Geospatial heterogeneity of hotspots for incidence and late-stage diagnosis of breast, colorectal, and lung cancer. Cancer Causes Control Loehrer AP, Carlos HA, Weiss JE, Wang Q, Leversedge CV, Katter JE, Phillips JD, Ferrari-Light D, Onega T, Shi X. PMID: 42189260 [PubMed - in process]
	Thyroid disease and breast cancer risk in the Sister Study. Cancer Epidemiol Biomarkers Prev Woo JMP, Chen D, Yarosh R, O'Brien KM, Sandler DP. PMID: 42189187 [PubMed - as supplied by publisher]
	Revolutionizing breast cancer treatment: the emerging role of biopolymers-based drug-eluting nanofibers. J Biomater Sci Polym Ed H Ali I, Hamdi M, Abouzid K, Abdel-Bar HM. PMID: 42189080 [PubMed - as supplied by publisher]
	Bidirectional Perceptual Multimodal Interaction Network Based on Contrastive Learning for Breast Cancer pCR Prediction. Tomography Feng J, Jiang Z, Zhang J. PMID: 42188715 [PubMed - in process]
	Quality of Life in Slovak Breast Cancer Survivors: A Cross-Sectional Study Using EORTC QLQ-C30 and BR23. Nurs Rep Zuborova P, Slamkova A, Mlyncek M, Visnovsky J, Bujnak J, Zubor P. PMID: 42188655 [PubMed - in process]
	Federated Learning with Differential Privacy for Ultrasound Breast Cancer Classification: An Empirical Study. J Imaging Makhanov N, Abdikenov B, Zhaksylyk T, Karibekov T. PMID: 42188242 [PubMed - in process]
	Circulating Lipid Traits and Ovarian Cancer Risk: A Systematic Review and Meta-Analysis with Mendelian Randomization Integration. Metabolites Marian M, Ardelean A, Rosu M, Tarta C, Isaic A, Brebu D, Marian C, Faur IA, Pasca P, Faur IF, Stoian D, Korodi A. PMID: 42187999 [PubMed - in process]
	EVG-Based Periarterial/Perivenous Invasion (periA/V) as a High-Sensitivity Surrogate Marker for Lymph Node Metastasis in pT1 Invasive Breast Carcinoma of No Special Type. Diseases Mashiba C, Shioya A, Takata T, Kumagai M, Shimasaki M, Oyama T, Haba Y, Morioka E, Inokuchi M, Yamada S. PMID: 42187889 [PubMed - in process]
	Development and Evaluation of a Web-Based App for Adverse Effect Management in Breast Cancer Patients Treated with Oral Targeted Therapy or Chemotherapy: Findings from a Pilot Study. Curr Oncol Lemieux J, Côté I, Lemay M, Lauzier S, Després P, Desbiens C, Doyle C, Poirier B, Baghdadli A, Di Schiavi Trotta L, Nabi H. PMID: 42187589 [PubMed - in process]
	Omission of Axillary Lymph Node Dissection in Breast Cancer Patients with 1-2 Positive Sentinel Lymph Nodes: A Multicenter Real-World Cohort Study in a Chinese Population. Curr Oncol Hong C, Chen J, Chen Y, Li L, Du X, Chen D, Lian W. PMID: 42187564 [PubMed - in process]
	Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025. Curr Oncol Simmons C, Khan OF, Brezden-Masley C, Cescon DW, Joy AA, LeVasseur N, Jerzak KJ, Gelmon KA, Sehdev S, Chia S, Webster M, Edwards S, Kumar A, Cao JQ, Boileau JF, Laing K, Bouganim N, Manna M, On Behalf Of Patient Advocacy Breast Cancer Canada. PMID: 42187560 [PubMed - in process]
	Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer. NEJM Evid Clemons M, Stober C, Pond GR, Conter H, Simos D, Dhesy-Thind S, Mates M, Trinkaus M, Hilton J, Savard MF, Fergusson D, Vandermeer L, Awan AA. PMID: 42187551 [PubMed - in process]
	Real-World Efficacy of Metronomic Chemotherapy in Advanced Breast Cancer Across Molecular Subtypes. Cancer Med Zhou H, Chen L, Lu Q, Wu H, Jiang K, Xu F, Wang S. PMID: 42187010 [PubMed - indexed for MEDLINE]
	Nanoscale Drug Delivery Systems for Ovarian Cancer: Targeting Strategies, Theranostic Platforms, and Translational Challenges. Small Hu X, Zhang Y, Lu Y, Zheng F, Zhang K, Jiang M, Chen C, Wei Z, Wang J. PMID: 42187005 [PubMed - as supplied by publisher]
	Association Between Body Mass Index and Breast Cancer Incidence in Non-Hispanic White and Black Women: Methodological Considerations From a Secondary Analysis of the Vitamin D and Omega-3 Trial Cohort. Cureus Oluwole OE, Jacobs DR, Aremu TO. PMID: 42186643 [PubMed]
	Impact of Distinct Molecular and Immunological Features of Breast Cancer on the Effectiveness of Therapies in Ghana. Breast Cancer (Auckl) Essilfie NK, Abakah A, Etsey M, Ofori-Amanfo D, Boampong K, Gyan BA, Kashala OL, Kwarteng EVS, Andam-Akorful SA, Paintsil V, Kwarteng A, Larbi AA. PMID: 42186480 [PubMed]
	Invasive lobular carcinoma: Shining a light on the second most prevalent type of breast cancer. Nurse Pract Csaky WL, Coombe AH, Kruse M. PMID: 42186108 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 329215

Seite 1 von 16461

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung